Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

Published:2017-03-23 Issue:12 Volume:129 Page:1685-1690
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Yeh Paul¹²³,Dickinson Michael²,Ftouni Sarah¹,Hunter Tane¹³,Sinha Devbarna¹,Wong Stephen Q.¹,Agarwal Rishu¹³,Vedururu Ravikiran¹,Doig Kenneth¹³,Fong Chun Yew¹³,Blombery Piers¹²,Westerman David¹²,Dawson Mark A.¹²³⁴^ORCID,Dawson Sarah-Jane¹²³⁴^ORCID

Affiliation:

1. Division of Cancer Research, and

2. Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and

3. Sir Peter MacCallum Department of Oncology, and

4. Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia

Abstract

Key PointsCirculating tumor DNA can monitor disease and predict treatment failure by tracking driver mutations and karyotypic abnormalities in MDS.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/12/1685/1399515/blood740308.pdf

Reference26 articles.

1. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

2. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

3. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes;Della Porta;Leukemia,2015

4. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers;Naqvi;Blood,2011

5. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes;Bernasconi;Br J Haematol,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

3. Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges;Frontiers in Bioscience-Landmark;2024-02-22

4. Early Detection of Molecular Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA;Clinical Cancer Research;2024-01-03

5. Blast-Derived Small Extracellular Vesicles in the Plasma of Patients with Acute Myeloid Leukemia Predict Responses to Chemotherapy;Biomedicines;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3